WuXi AppTec stock receives CRDMO award ahead of Xetra open
Published on 10/20/2026 at 08:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRecognition and trading context
- WuXi AppTec received Frost & Sullivan's 2026 CRDMO Global Company of the Year recognition on October 19, 2026.
- A PR Newswire release described the company's integrated CRDMO model across the drug development lifecycle on October 19, 2026.
- WuXi AppTec stock trades pre-market at EUR 22.11 at 8:13 a.m. CEST at Lang & Schwarz on October 20, 2026.
WuXi AppTec received Frost & Sullivan's 2026 Global Company of the Year recognition in the contract research, development and manufacturing organization industry on October 19, 2026, according to a PR Newswire release carried by Fidelity. WuXi AppTec stock trades pre-market at EUR 22.11 at 8:13 a.m. CEST at Lang & Schwarz on October 20, 2026.
CRDMO recognition
The recognition covers WuXi AppTec's CRDMO activities, which support customers from early drug discovery through commercial manufacturing, the PR Newswire release said. It identified the company's integrated model, global capacity and ability to adapt to complex modalities among the points highlighted by Frost & Sullivan.
Ahead of the Xetra open
The pre-market indication was recorded at Lang & Schwarz at 8:13 a.m. CEST. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of WuXi AppTec stock.
Business and market context
WuXi AppTec's investor-relations material describes an integrated CRDMO business that provides research, development and manufacturing services for pharmaceutical and life-sciences customers. Market context: Market report Shanghai Composite.
